Abstract
Allogeneic bone marrow transplantation (allo-BMT) has been used as a therapeutic procedure for hematological malignancies and diseases unresponsive to chemotherapy. Despite its increasing application, allo-BMT is associated with significant morbidity and mortality. Graft-versus-host disease (GvHD) is the main complication and cause of death after BMT, affecting 30-70% of patients. Studies…